Can syringe exchange serve as a conduit to substance abuse treatment?

Journal of Substance Abuse Treatment

Volumn 15, Issue 3, 1998, Pages 183-191

  Heimer, Robert ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HIV AIDS prevention; Managed care; Needle syringe exchange; Substance abuse treatment

Indexed keywords

ARTICLE; DRUG DEPENDENCE TREATMENT; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INTRAVENOUS DRUG ABUSE; PRIORITY JOURNAL; SUBSTANCE ABUSE; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; CONNECTICUT; FEMALE; HUMANS; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; NEEDLE-EXCHANGE PROGRAMS; SUBSTANCE-RELATED DISORDERS; SYRINGES;

EID: 0031814083     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0740-5472(97)00220-1     Document Type: Article

References (25)

1. Blix O., Gröbladh L. The impact of methadone maintenance treatment on the spread of HIV among heroin addicts in Sweden. Loimer N., Schmid R., Springer A. Drug addiction and AIDS. 1991;200-205 Springer-Verlag, Vienna.
2. Caplehorn J.R.M., Ross M.W. Methadone maintenance and the likelihood of risky needle-sharing. International Journal of Addictions. 30:1995;685-698.
3. Des Jarlais D.C., Friedman S.R., Sotheran J.L., Wenston J., Marmor M., Yancovitz S.R., Frank B., Beatrice S., Mildvan D. Continuity and change within an HIV epidemic. Journal of the American Medical Association. 271(2):1994;121-127.
4. Friedman S.R., Jose B., Deren S., Des Jarlais D.C., Neaigus A. Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low prevalence cities. American Journal of Epidemiology. 142:1995;864-874.
5. Heimer R., Kaplan E.H., Khoshnood K., Jariwala B., Cadman E.C. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in, New Haven, CT. American Journal of Medicine. 95:1993;214-220.
6. Heimer R., Kaplan E.H., O'Keefe E., Khoshnood K., Altice F. Three years of needle exchange in New Haven. What have we learned? AIDS and Public Policy Journal. 9:1994;59-74.
7. Heimer R., Khoshnood K., Jariwala-Freeman B., Duncan B., Harima Y. Hepatitis in used syringes. The limits of sensitivity of techniques to detect HBV DNA, HCV RNA, and antibodies to HB core and HCV antigens Journal of Infectious Diseases. 173:1996;997-1000. a.
8. Heimer R., Khoshnood K., Stephens P.C., Jariwala-Freeman B., Kaplan E.H. Evaluating a needle exchange programme. Models for testing HIV-1 risk reduction International Journal of Drug Policy. 7:1996;123-129. b.
9. Heimer R., Lopes M. Syringe and needle exchange to prevent HIV infection (letter). Journal of the American Medical Association. 271:1994;1825-1826.
10. Holmberg S.D. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. American Journal of Publ. Health. 86:1996;642-654.
11. Kaplan E.H. Evaluating needle exchange programs via syringe tracking and testing. AIDS and Public Policy Journal. 6(3):1991;109-115.
12. Kaplan E.H. Operational modeling of needle exchange programs. Institute of National Research Council & Medicine (Ed.), Workshop on needle exchange and bleach distribution programs. 1994;202-249 National Academy Press, Washington, DC.
13. Kaplan E.H., Heimer R. HIV prevalence among injecting drug users. model-based estimates from New Haven's legal needle exchange Journal Acquired Immune Deficiency Syndrome. 5:1992;163-169.
14. Kaplan E.H., Heimer R. A circulation theory of needle exchange. AIDS. 8:1994;567-574.
15. Kaplan E.H., O'Keefe E. Let the needles do the talking! Evaluating the New Haven needle exchange. Interfaces. 23(1):1993;7-26.
16. Lurie, P., & Reingold, A.L. (1993). The public health impact of needle exchange programs in the United States and abroad. University of California and the Centers for Disease Control and Prevention.
17. Martinez B. Needle exchange programs: Are they effective. (No. Bulletin 7). 1992;Office of National Drug Control Policy, Washington, DC.
18. Metzger D.S., Woody G.E., McLellan A.T., O'Brien C.P., Druley P., Navaline H., DePhillippis D., Stolley P., Abrutyn E. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment. An 18-month prospective follow-up Journal of Acquired Immune Deficiency Syndrome. 6:1993;1049-1056.
19. Moss A.R., Vranizan K., Gorter R., Bacchetti P., Watters J., Osmond D. HIV seroconversion in intravenous drug users in San Francisco, 1985-1990. AIDS. 8:1994;223-231.
20. Nadel M.V. Needle exchange programs: Research suggests promise as an AIDS prevention strategy. (No. GAO/HRD-93-60). 1993;United States General Accounting Office, Washington, DC.
21. Normand J., Vlahov D., Moses L.E. Preventing HIV transmission. The role of sterile needles and bleach:1995;National Academy Press, Washington, DC.
22. Novick D.M., Joseph H., Croxson T.S., Salsitz E.A., Wang G., Richman B.L., Poretsky L., Keefe J.B., Whimbey E. Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitated methadone maintenance patients. Archives of Internal Medicine. 150:1990;97-99.
23. Paone D., Des Jarlais D.C., Clark J., Shi Q., Purchase D., Crim M. Syringe exchange programs in the United States, 1996-97. Mortality and Morbidity Weekly Report. 46:1997;565-568.
24. Rawson R.A., McCann M.J., Hasson A.J., Ling W. Cocaine abuse among methadone maintenance patients. Are there effective treatment strategies? Journal of Psychoactive Drugs. 26(2):1994;129-136.
25. Withers N.W., Pulvirenti L., Koob G.F., Gillin J.C. Cocaine abuse and dependence. Journal of Clinical Psychopharmacology. 15:1995;63-78.